Clara Natoli

8.4k citations

151 papers · 4.8k indexed · h-index 34

Impact in

Immunology top 1%
- Galectins and Cancer Biology
- Toxin Mechanisms and Immunotoxins
Oncology top 1%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 74
- HER2/EGFR in Cancer Research 16
- Cancer Treatment and Pharmacology 16
- Cancer Immunotherapy and Biomarkers 14
Immunology 47
- Galectins and Cancer Biology 37
- Toxin Mechanisms and Immunotoxins 14

Co-authors: Stefano Iacobelli Nicola Tinari Fu‐Tong Liu Antonino Grassadonia Gabriel A. Rabinovich Roberto Paganelli Linda G. Baum Domenico Angelucci
Journals: International Journal of Cancer (8 papers)Oncotarget (8 papers)Annals of Oncology (6 papers)Journal of Clinical Oncology (5 papers)British Journal of Cancer (4 papers)
Partner nations: Italy United States Malaysia

In The Last Decade

Clara Natoli

149 papers receiving 4.7k citations

Peers

Countries citing papers authored by Clara Natoli

Since Specialization

Citations

This map shows the geographic impact of Clara Natoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Natoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Natoli more than expected).

Fields of papers citing papers by Clara Natoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Natoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Natoli. The network helps show where Clara Natoli may publish in the future.

Co-authors

The 25 scholars most cited alongside Clara Natoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Clara Natoli Line = papers co-authored together Clara Natoli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting Cells ·Antonino Grassadonia, Vincenzo Graziano, Laura Iezzi, Patrizia Vici, Maddalena Barba, Laura Pizzuti, Giuseppe Cicero, Eriseld Krasniqi, Marco Mazzotta, Daniele Marinelli, Antonella Amodio, Clara Natoli, Nicola Tinari	2021	28
2	Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression Cell Death Discovery ·Antonino Grassadonia, Vincenzo Graziano, Sara Pagotto, Angelo Veronese, Cesidio Giuliani, Marco Marchisio, Paola Lanuti, Michele De Tursi, Maurizia DʼEgidio, Pietro Di Marino, Davide Brocco, Patrizia Vici, Laura De Lellis, Alessandro Cama, Clara Natoli, Nicola Tinari	2021	5
3	Long-term outcome of pemetrexed maintenance for advanced nonsquamous non-small-cell lung cancer: a real-world observational cohort study Recenti Progressi in Medicina ·Fabrizio Nelli, Agnese Fabbri, Luca Moscetti, Isabella Sperduti, Teresa Gamucci, Giovanni Mansueto, Carlo Signorelli, Enrico Cortesi, Olga Martelli, Clara Natoli, Francesco Angelini, Enzo Maria Ruggeri	2020	2
4	Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib SHILAP Revista de lepidopterología ·Jamie Roebuck, Pierre A. Cossette, Swa Swb, Antonino Grassadonia, Nicola Tinari, Clara Natoli, 裕貴石田	2020	2
5	Gender and outcome of patients receiving immune checkpoint inhibitors in the treatment of advanced cancer Antonino Grassadonia, Michele De Tursi, Isabella Sperduti, Clara Natoli, Maddalena Barba, Nicola Tinari	2020	1
6	The Adherence to Hormonal Deprivation Therapy for Prostate Cancer in a Real Life Contest: Retrospective, Single-Centre Study Antonio Aliberti, Maida Bada, Ozana de Oliveira Barbosa, Clara Natoli, Luigi Schips, Luca Cindolo	2017	1
7	Interleukin-30 Promotes Breast Cancer Growth and Progression Cancer Research ·Irma Airoldi, Claudia Cocco, Carlo Sorrentino, Domenico Angelucci, 美恵子室井, Lamberto Manzoli, Silvia Esposito, Doménico Ribatti, Maria Bertolotto, Laura Iezzi, Clara Natoli, Emma Di Carlo	2016	32
8	Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? Cancer Biology & Therapy ·Vincenzo Graziano, Janara Alexandre Nunes, W.C. Nusbaum, 三智志賀, Patrizia Vici, Clara Natoli, Antonino Grassadonia	2015	6
9	Inhibition of Tumor Growth and Angiogenesis by SP-2, an Anti–Lectin, Galactoside-Binding Soluble 3 Binding Protein (LGALS3BP) Antibody Molecular Cancer Therapeutics ·Sara Traini, Enza Piccolo, Nicola Tinari, Cosmo Rossi, Rossana La Sorda, Francesca Spinella, Anna Bagnato, Rossano Lattanzio, Maurizia DʼEgidio, http://lattes.cnpq.br/1802952788538732, Federica Tomao, Antonino Grassadonia, Mauro Piantelli, Clara Natoli, Stefano Iacobelli	2014	28
10	Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. PubMed ·Ida Iurisci, Albana Cumashi, 田鶴子増森, 卢玉娥, Nicola Tinari, Enza Piccolo, Maurizia DʼEgidio, Vincenzo Adamo, Clara Natoli, Gabriel A. Rabinovich, Stefano Iacobelli, Nikolay E. Nifantiev	2009	55
11	90K (Mac-2 BP) and galectins in tumor progression and metastasis Glycoconjugate Journal ·Antonino Grassadonia, Nicola Tinari, Ida Iurisci, Enza Piccolo, Min XiaoHui, Pasquale F. Innominato, Maurizia DʼEgidio, Clara Natoli, Mauro Piantelli, Stefano Iacobelli	2002	147
12	Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K. PubMed ·L. Carmans, Sylvia Stadlmann, Clara Natoli, Martin Widschwendter, Martin Hermann, Burghard Abendstein, Ralf-Dieter Hilgers, Felix Offner, S. Iacobelli, Ch. Marth	2001	7
13	Concentrations of galectin-3 in the sera of normal controls and cancer patients. PubMed ·Ida Iurisci, Nicola Tinari, Clara Natoli, Domenico Angelucci, Ettore Cianchetti, S. Iacobelli	2000	243
14	90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L. PubMed ·Nicola Tinari, Clara Natoli, Prajanphanit, F Ghinelli, L Sighinolfi, L Ortona, Enrica Tamburrini, L. Brochier, Antonio Chirianni, Saketh Nallagatla, Patrizia Di Gregorio, Stefano Iacobelli	1998	7
15	Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients Journal of Hepatology ·Marco Artini, Clara Natoli, Nicola Tinari, Antonio Costanzo, T.D. Beaty, Clara Balsano, S. Omanette, Domenico Angelucci, Maurizia DʼEgidio, Massimo Levrero, Stefano Iacobelli	1996	83
16	Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitis. PubMed ·N Gentiloni, P Caradonna, Guido Costamagna, Prajanphanit, Vincenzo Perri, Massimiliano Mutignani, Ιωάννης Μάσσας, Nicola Tinari, Silvia Iacobelli, Clara Natoli	1995	22
17	90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. PubMed ·Clara Natoli, F. Dianzani, F. Mazzotta, Emanuela Balocchini, Piera Pierotti, Guido Antonelli, Stefano Iacobelli	1993	31
18	A 90-kDa Protein Serum Marker for the Prediction of Progression to AIDS in a Cohort of HIV-1 ⁺ Homosexual Men AIDS Research and Human Retroviruses ·Nathaniel C. Briggs, Clara Natoli, Nicola Tinari, Maurizia DʼEgidio, James J. Goedert, Stefano Iacobelli	1993	30
19	Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer. PubMed ·M Giai, Clara Natoli, P Sismondi, Nicoletta Biglia, G. Lesti, HerculesH. Macdonnell, Stefano Iacobelli	1990	7
20	Gastric carcinoma associated with severe hypoglycemia sensitive to diazoxide. PubMed ·G. Tamburrano, Lucas Tadeu Andrade, Clara Natoli, Valarie Lee Pei Sze, D Andreani	1979	1

About Clara Natoli

Clara Natoli is a scholar working on Oncology, Immunology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 151 papers that have together received 4.8k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (37 papers), Glycosylation and Glycoproteins Research (22 papers), HER2/EGFR in Cancer Research (16 papers), Cancer Treatment and Pharmacology (16 papers), Breast Cancer Treatment Studies (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), Estrogen and related hormone effects (14 papers) and Toxin Mechanisms and Immunotoxins (14 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (1.7k citations), Cancer Research (509 citations), Molecular Biology (2.0k citations) and Pharmacology (424 citations). Clara Natoli has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Stefano Iacobelli, Nicola Tinari, Fu‐Tong Liu, Antonino Grassadonia, Gabriel A. Rabinovich, Roberto Paganelli, Linda G. Baum, Domenico Angelucci, Ida Iurisci and Paola Matarrese. Their work appears in journals such as International Journal of Cancer, Oncotarget, Annals of Oncology, Journal of Clinical Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact